US Paediatrician Attacks Surrogacy
By Michael Cook,
BioEdge
| 05. 03. 2014
Supporters of surrogacy often claim that on the whole, women in developing countries benefit from the system, as they earn years of wages from a single pregnancy. However, a paediatrician at the Mayo Graduate School of Medicine, in Minnesota, has published a blistering rebuttal in the
International Journal of Gynecology & Obstetrics. Jonathan W. Knoche writes:
On a psychological and philosophical level, the acceptance of international surrogacy requires an alteration of the view of a woman and the process of reproduction. The international market of industrialized reproduction necessitates the uterus to be viewed as a mere commodity—something distinct from the whole woman. Within this market-oriented mentality, the commodity of a womb is fungible (i.e. any one of them can be substituted for any other similar commodity, given that the quality and price are the same). Thus, a gestational surrogate is essentially seen as a glorified incubator. Carriers become commodities. To view human persons as parts or commodities primarily for our use and exploitation is dubious. No human being—or her parts—should be treated as a commodity precisely because we are...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Emile Torres, Jacobin | 11.15.2025
Watching tech moguls throw caution to the wind in the AI arms race or equivocate on whether humanity ought to continue, it’s natural to wonder whether they care about human lives.
The earnest, in-depth answer to this question is just...